Abpro Bio Co., Ltd. (KOSDAQ:195990)
310.00
-1.00 (-0.32%)
Last updated: Apr 1, 2025
Abpro Bio Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | -15,629 | -25,742 | -8,145 | -10,030 | -58,972 | Upgrade
|
Depreciation & Amortization | 1,484 | 1,870 | 1,402 | 2,625 | 7,248 | Upgrade
|
Loss (Gain) From Sale of Assets | -11,797 | 79.93 | -142.24 | -1,013 | -218.45 | Upgrade
|
Asset Writedown & Restructuring Costs | 2,191 | 254.14 | - | 748.73 | 11,489 | Upgrade
|
Loss (Gain) From Sale of Investments | -7.36 | 3,238 | -2,218 | 3,950 | 974.88 | Upgrade
|
Loss (Gain) on Equity Investments | 27,881 | 9,377 | -4,219 | 5,876 | 13,194 | Upgrade
|
Stock-Based Compensation | - | - | - | 260.5 | 334.8 | Upgrade
|
Provision & Write-off of Bad Debts | -3,782 | 195.08 | -17.77 | -1,209 | 1,396 | Upgrade
|
Other Operating Activities | -9,327 | 3,750 | 6,387 | -3,969 | 20,727 | Upgrade
|
Change in Accounts Receivable | 1,676 | 133.03 | -488.08 | 2,519 | -1,328 | Upgrade
|
Change in Inventory | 4,461 | 4,677 | -3,553 | 1,461 | 10,901 | Upgrade
|
Change in Accounts Payable | -1,190 | -996.65 | -1,347 | 567.74 | 659.82 | Upgrade
|
Change in Unearned Revenue | - | - | - | - | -2,299 | Upgrade
|
Change in Income Taxes | - | - | - | 0.01 | - | Upgrade
|
Change in Other Net Operating Assets | -1,713 | -1,698 | -119.35 | -4,005 | -1,346 | Upgrade
|
Operating Cash Flow | -5,752 | -4,862 | -12,461 | -2,220 | 2,761 | Upgrade
|
Operating Cash Flow Growth | - | - | - | - | 3.29% | Upgrade
|
Capital Expenditures | -17,109 | -1,148 | -132.25 | -542.24 | -270.79 | Upgrade
|
Sale of Property, Plant & Equipment | 28,932 | 60.11 | 5.18 | 53.1 | 637.36 | Upgrade
|
Cash Acquisitions | -9,986 | -7,155 | - | - | -355.97 | Upgrade
|
Divestitures | - | - | - | 1,606 | - | Upgrade
|
Sale (Purchase) of Intangibles | 1,193 | -1,090 | 1,347 | -3,244 | -382.78 | Upgrade
|
Investment in Securities | -8,198 | 16,416 | -14,012 | -161 | 149.89 | Upgrade
|
Other Investing Activities | 2,442 | 134.18 | -7,663 | 4,846 | 19.23 | Upgrade
|
Investing Cash Flow | -6,788 | 5,633 | -21,352 | 8,348 | -405.95 | Upgrade
|
Short-Term Debt Issued | 5,593 | - | - | - | 2,604 | Upgrade
|
Long-Term Debt Issued | 17,240 | 6,900 | - | 14,616 | 10,000 | Upgrade
|
Total Debt Issued | 22,833 | 6,900 | - | 14,616 | 12,604 | Upgrade
|
Short-Term Debt Repaid | -5,677 | -150 | - | -56.83 | -3,101 | Upgrade
|
Long-Term Debt Repaid | -8,582 | -5,572 | -3,373 | -236.25 | -390.08 | Upgrade
|
Total Debt Repaid | -14,259 | -5,722 | -3,373 | -293.08 | -3,491 | Upgrade
|
Net Debt Issued (Repaid) | 8,573 | 1,178 | -3,373 | 14,323 | 9,113 | Upgrade
|
Issuance of Common Stock | - | - | - | 5,980 | - | Upgrade
|
Other Financing Activities | -0 | -0 | - | - | 220.68 | Upgrade
|
Financing Cash Flow | 8,573 | 1,178 | -3,373 | 20,303 | 9,334 | Upgrade
|
Foreign Exchange Rate Adjustments | 604.41 | -44.09 | 177.25 | 688.93 | 476.48 | Upgrade
|
Miscellaneous Cash Flow Adjustments | - | - | - | - | -281.82 | Upgrade
|
Net Cash Flow | -3,362 | 1,905 | -37,009 | 27,120 | 11,883 | Upgrade
|
Free Cash Flow | -22,861 | -6,011 | -12,593 | -2,762 | 2,490 | Upgrade
|
Free Cash Flow Margin | -72.20% | -23.69% | -56.95% | -8.39% | 6.96% | Upgrade
|
Free Cash Flow Per Share | -80.30 | -21.60 | -46.94 | -10.24 | 11.62 | Upgrade
|
Cash Interest Paid | 628.37 | 417.18 | 397.92 | 400.65 | 742.19 | Upgrade
|
Cash Income Tax Paid | -0.05 | 138.89 | -34.96 | 130.45 | 24.94 | Upgrade
|
Levered Free Cash Flow | -19,266 | -6,703 | -6,719 | -12,719 | 17,127 | Upgrade
|
Unlevered Free Cash Flow | -17,960 | -5,240 | -3,849 | -8,432 | 20,219 | Upgrade
|
Change in Net Working Capital | -561.61 | -1,489 | -530.42 | 4,198 | -14,471 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.